Hims & Hers Health Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
/ 
Hims & Hers Health, Inc. (HIMS) is a U.S.-based telehealth company that offers direct-to-consumer healthcare services and wellness products through a digital platform. Founded in 2017 and headquartered in San Francisco, California, the company connects users with licensed healthcare professionals for the treatment of common conditions in mental health, dermatology, sexual health, and primary care.
Through its website and mobile app, Hims & Hers enables users to complete virtual consultations—often asynchronously—and receive personalised treatment plans, with medications and wellness products delivered to their homes. The company operates under two consumer-facing brands: Hims (targeting men) and Hers (targeting women), both of which offer subscription-based access to prescription and over-the-counter products.
Hims & Hers also sells wellness and personal care items through e-commerce and retail partnerships. Its vertically integrated model combines pharmacy fulfilment, clinical operations, and proprietary technology to enhance accessibility, affordability, and user experience across routine and preventive care.
Hims & Hers Health is listed on the New York Stock Exchange (NYSE).
Saxo provides this content for general information only. It is not intended as personal advice, an offer, or a recommendation. Saxo does not guarantee accuracy or completeness and accepts no liability for losses. Consider obtaining independent advice before any investment decision.
Others were interested in
See all stocksFrequently asked questions
To buy Hims & Hers Health Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Hims & Hers Health Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Hims & Hers Health Inc. is HIMS:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Hims & Hers Health Inc. has its primary listing on New York Stock Exchange. You can trade Hims & Hers Health Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Hims & Hers Health Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Hims & Hers Health Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Hims & Hers Health Inc..